Clinical trials by condition
Age-related macular degeneration (AMD) clinical trials near you
100 studies for age-related macular degeneration (AMD) are recruiting volunteers at 797 research sites in 44 states.
Also called macular degeneration, ARMD.
Part of Retina and macula diseases
- Studies recruiting
- 100
- Research sites
- 797
- States
- 44
What is age-related macular degeneration (AMD)?
Age-related macular degeneration (AMD) is an eye disease that can blur or damage central vision, the sharp, straight-ahead sight used for reading or driving. It affects the macula, the part of the retina that lets the eye see fine detail. It usually is not painful and can affect one eye or both.
There are two types. Dry AMD is the more common one: the macula gets thinner with age, and vision is usually lost slowly. Wet AMD happens when abnormal blood vessels grow under the macula and leak blood and fluid; it is less common but damages the macula quickly. The cause is unknown and is thought to be a mix of aging, genes and lifestyle.
AMD gets worse over time. Treatment depends on the type and stage. Certain vitamins and minerals may help slow some dry AMD, but they do not bring back lost vision. Wet AMD is most often treated with medicine injected into the eye, which may slow or stop further vision loss.
Written with AI from MedlinePlus, the National Library of Medicine's health information, and checked by an AI medical reviewer on November 13, 2026. Read more on MedlinePlus
Types of age-related macular degeneration (AMD)
Each type has its own page with the studies recruiting for it. The figures on this page include them.
- Dry age-related macular degeneration (geographic atrophy)not enough studies for a page yet
- Wet age-related macular degenerationnot enough studies for a page yet
Areas with the most age-related macular degeneration (AMD) studies
Metro areas where studies for age-related macular degeneration (AMD) are recruiting, each study counted once in an area.
By state
Studies for age-related macular degeneration (AMD) recruiting in each state.
- Texas56 studies · 121 sites
- California46 studies · 121 sites
- Florida39 studies · 88 sites
- Pennsylvania34 studies · 29 sites
- Maryland30 studies · 26 sites
- Arizona25 studies · 34 sites
- Massachusetts25 studies · 19 sites
- New York22 studies · 31 sites
- Illinois21 studies · 28 sites
- North Carolina21 studies · 33 sites
All 44 states
- Texas56
- California46
- Florida39
- Pennsylvania34
- Maryland30
- Arizona25
- Massachusetts25
- New York22
- Illinois21
- North Carolina21
- Ohio19
- South Carolina19
- Connecticut18
- Oregon18
- Virginia18
- Indiana17
- Colorado16
- Tennessee16
- New Jersey15
- Michigan14
- Nevada14
- Washington14
- Georgia12
- Minnesota11
- Mississippi11
- Wisconsin11
- Missouri10
- Utah10
- New Mexico6
- South Dakota6
- Kansas5
- Iowa4
- Oklahoma4
- Arkansas3
- Maine3
- North Dakota3
- West Virginia3
- Kentucky2
- Louisiana2
- Alabama1
- Hawaii1
- Nebraska1
- New Hampshire1
- Vermont1
Whom the studies accept
The share of the age-related macular degeneration (AMD) studies open to each group. A study can accept several.
- Adults 18 to 6496%
- Adults 65 and over95%
- Children and teens (under 18)23%
- Healthy volunteers20%
- Open to all sexes100%
Study phases
Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.
- Early phase 12%
- Phase 111%
- Phase 1/219%
- Phase 218%
- Phase 2/33%
- Phase 312%
- No phase (device, behavioral and other studies)11%
- Not stated24%
Cite these figures
Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.
Source: LocalTrial, Age-related macular degeneration (AMD) clinical trials near you, https://www.localtrial.com/clinical-trials/conditions/age-related-macular-degeneration, updated November 13, 2026.
Source: <a href="https://www.localtrial.com/clinical-trials/conditions/age-related-macular-degeneration">LocalTrial, Age-related macular degeneration (AMD) clinical trials near you</a>, updated November 13, 2026.
About these figures
Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States that study age-related macular degeneration (AMD). A study is counted once however many sites it has.
Updated November 13, 2026.
These figures describe studies, not advice. Talk to your doctor before joining one.
Tell us a little about yourself and we'll suggest the age-related macular degeneration (AMD) studies near you that may fit. Free and private.
Ready to see what's near you?
Find age-related macular degeneration (AMD) studies near me